MedPath

SAN-711

Generic Name
SAN-711

First-in-human Study of SAN711 in Healthy Participants

Phase 1
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Saniona
Target Recruit Count
80
Registration Number
NCT04971135
Locations
🇬🇧

Hammersmith Medicines Research (HMR), London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath